172 related articles for article (PubMed ID: 9317174)
1. Identification of allelic losses in benign, borderline, and invasive epithelial ovarian tumors and correlation with clinical outcome.
Saretzki G; Hoffmann U; Röhlke P; Psille R; Gaigal T; Keller G; Höfler H; Löning T; Petersen I; Dietel M
Cancer; 1997 Oct; 80(7):1241-9. PubMed ID: 9317174
[TBL] [Abstract][Full Text] [Related]
2. Comparison of loss of heterozygosity patterns in invasive low-grade and high-grade epithelial ovarian carcinomas.
Dodson MK; Hartmann LC; Cliby WA; DeLacey KA; Keeney GL; Ritland SR; Su JQ; Podratz KC; Jenkins RB
Cancer Res; 1993 Oct; 53(19):4456-60. PubMed ID: 8402612
[TBL] [Abstract][Full Text] [Related]
3. Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization.
Hauptmann S; Denkert C; Koch I; Petersen S; Schlüns K; Reles A; Dietel M; Petersen I
Hum Pathol; 2002 Jun; 33(6):632-41. PubMed ID: 12152163
[TBL] [Abstract][Full Text] [Related]
4. Potential role of the inactivated X chromosome in ovarian epithelial tumor development.
Cheng PC; Gosewehr JA; Kim TM; Velicescu M; Wan M; Zheng J; Felix JC; Cofer KF; Luo P; Biela BH; Godorov G; Dubeau L
J Natl Cancer Inst; 1996 Apr; 88(8):510-8. PubMed ID: 8606379
[TBL] [Abstract][Full Text] [Related]
5. 3p21, 5q21, and 9p21 allelic deletions are frequently found in normal bronchial cells adjacent to non-small-cell lung cancer, while they are unusual in patients with no evidence of malignancy.
Sanz-Ortega J; Saez MC; Sierra E; Torres A; Balibrea JL; Hernando F; Sanz-Esponera J; Merino MJ
J Pathol; 2001 Nov; 195(4):429-34. PubMed ID: 11745674
[TBL] [Abstract][Full Text] [Related]
6. Allelotyping defines minimal imbalance at chromosomal region 17q25 in non-serous epithelial ovarian cancers.
Dion F; Mes-Masson AM; Seymour RJ; Provencher D; Tonin PN
Oncogene; 2000 Mar; 19(11):1466-72. PubMed ID: 10723138
[TBL] [Abstract][Full Text] [Related]
7. Molecular genetic changes in human epithelial ovarian malignancies.
Gallion HH; Powell DE; Morrow JK; Pieretti M; Case E; Turker MS; DePriest PD; Hunter JE; van Nagell JR
Gynecol Oncol; 1992 Nov; 47(2):137-42. PubMed ID: 1468689
[TBL] [Abstract][Full Text] [Related]
8. Allelotype of papillary serous peritoneal carcinomas.
Cass I; Baldwin RL; Fasylova E; Fields AL; Klinger HP; Runowicz CD; Karlan BY
Gynecol Oncol; 2001 Jul; 82(1):69-76. PubMed ID: 11426964
[TBL] [Abstract][Full Text] [Related]
9. A common region of deletion on chromosome 17q in both sporadic and familial epithelial ovarian tumors distal to BRCA1.
Godwin AK; Vanderveer L; Schultz DC; Lynch HT; Altomare DA; Buetow KH; Daly M; Getts LA; Masny A; Rosenblum N
Am J Hum Genet; 1994 Oct; 55(4):666-77. PubMed ID: 7942844
[TBL] [Abstract][Full Text] [Related]
10. Distinct allelic loss patterns in papillary serous carcinoma of the peritoneum.
Huang LW; Garrett AP; Schorge JO; Muto MG; Bell DA; Welch WR; Berkowitz RS; Mok SC
Am J Clin Pathol; 2000 Jul; 114(1):93-9. PubMed ID: 10884804
[TBL] [Abstract][Full Text] [Related]
11. Detailed deletion mapping of chromosome 9p and p16 gene alterations in human borderline and invasive epithelial ovarian tumors.
Rodabaugh KJ; Biggs RB; Qureshi JA; Barrett AJ; Welch WR; Bell DA; Berkowitz RS; Mok SC
Oncogene; 1995 Oct; 11(7):1249-54. PubMed ID: 7478544
[TBL] [Abstract][Full Text] [Related]
12. Expression of BRCA1 protein in benign, borderline, and malignant epithelial ovarian neoplasms and its relationship to methylation and allelic loss of the BRCA1 gene.
Wang C; Horiuchi A; Imai T; Ohira S; Itoh K; Nikaido T; Katsuyama Y; Konishi I
J Pathol; 2004 Feb; 202(2):215-23. PubMed ID: 14743504
[TBL] [Abstract][Full Text] [Related]
13. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas.
Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC
Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105
[TBL] [Abstract][Full Text] [Related]
14. LOH of chromosome 6q compared with LOH of 17q and 18q in ovarian cancers: relationship to p53 expression and clinicopathological findings.
Aguiari G; Martinello R; Casaro D; Rossi S; Piva R; Mollica G; Cavazzini P; Del Senno L
Int J Gynecol Cancer; 1999 Mar; 9(2):147-155. PubMed ID: 11240757
[TBL] [Abstract][Full Text] [Related]
15. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic changes associated with ovarian cancer.
Weitzel JN; Patel J; Smith DM; Goodman A; Safaii H; Ball HG
Gynecol Oncol; 1994 Nov; 55(2):245-52. PubMed ID: 7959292
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity of chromosome 17 in human borderline and invasive epithelial ovarian tumors.
Wertheim I; Tangir J; Muto MG; Welch WR; Berkowitz RS; Chen WY; Mok SC
Oncogene; 1996 May; 12(10):2147-53. PubMed ID: 8668340
[TBL] [Abstract][Full Text] [Related]
18. Human epithelial ovarian cancer allelotype.
Cliby W; Ritland S; Hartmann L; Dodson M; Halling KC; Keeney G; Podratz KC; Jenkins RB
Cancer Res; 1993 May; 53(10 Suppl):2393-8. PubMed ID: 8485726
[TBL] [Abstract][Full Text] [Related]
19. Incidence of loss of heterozygosity at p53 and BRCA1 loci in serous surface carcinoma.
Quezado MM; Moskaluk CA; Bryant B; Mills SE; Merino MJ
Hum Pathol; 1999 Feb; 30(2):203-7. PubMed ID: 10029450
[TBL] [Abstract][Full Text] [Related]
20. Ovarian epithelial tumors of low malignant potential: are they precursors of ovarian carcinoma?
Fukumoto M; Nakayama K
Pathol Int; 2006 May; 56(5):233-9. PubMed ID: 16669871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
